HIV Resistance mutations Flashcards

1
Q

M184V - Affected class

A

NRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

M184V - high level resistance (2)

A

3TC (lamivudine)

FTC (emtricitabine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

M184V - low level resistance (2)

A

ddI (didanosine)

ABC (abacavir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

M184V - Increased susceptibility (3)

A

ZDV (zidovudine)
d4T (stavudine)
TDF (tenofovir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

M184V - mechanism

A

Decreases NRTI incorporation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Thymidine analog mutations (TAMs) - Resistance (2)

A

ZDV (zidovudine)

d4T (stavudine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TAMs mildly resistance (3)

A

ABC (abacavir)
ddI (didanosine)
TDF (tenofovir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TAM mechanism

A

Enhanced removal of incorporated NRTI by promoting phosphorolytic reaction that leads to primer unblocking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Needed for high-level ABC and ddI resistance

A

M184V and 3+ TAMs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

M41L
L210W
T215Y

A

Type I TAMs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

D67N
K70R
T215F
K219Q/E

A

Type II TAMs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

4+ Of 41, 67, 70, 210, 215, 219

A

Resistance to all NRTIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs to Type I TAMs cause cross-resistance to? (3)

A

ABC
ddI
TDF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

K65R Resistance

A

All NRTI except ZDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

K65R - Increased susceptibility (1)

A

ZDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

L74V - Intermediate resistance (2)

A

ddI

ABC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

L74V - Slight increase susceptibility (2)

18
Q

NNRTI Resistance mechanisms

A

NNRTIs inhibit reverse transcriptase by binding hydrophobic pocket close but not contiguous with RT active site, mutations are within pockets or adjacent residues

19
Q

Primary NNRTI resistance mutations

A
K103N/S
V106A/M
Y181C/I/V
Y188L/C/H
G190A/S/E
E138K
20
Q

K103N resistance

A

EFV (efavirenz)

NVP (Nevirapine)

21
Q

V106

A

Resistance to DRV

22
Q

T69 insertion selected by

23
Q

T69 insertion high level resistance

A

Tenofovir
ABC
DDI

24
Q

T69 insertion decreased susceptibility (2)

25
Q

Q151m selected by

26
Q

Q151M High level resistance

A

ABC
DDI
Thymidine analogs

27
Q

Q151 low level resistance

A

3tc
FTC
Tenofovir

28
Q

K103N high level resistance

A

EFV
NVP
(Rilpivirine and etravirine susceptible)

29
Q

Y181C selected by

A

Nevirapine

30
Q

Y181C resistance (one high level, 3 low)

What NNRTI still works?

A

High level R nevirapine
Decreased susceptibility to EFV, RPV, ETV)

Doravirine still works (only)!

31
Q

E138K selected by

32
Q

E138K resistance

A

Decreased susceptibility to RPV, ETR, causes failure with K101E

33
Q

Q148R selected by

34
Q

Q148R resistance

A

High level to Raltegravir, elvitegravir
Also R to bic and dtg
Increase dolutegravir to bid if present

35
Q

N155H resistance

A

High level resistance to RAL, EVG

Decreased DTG and BIC if Q148R also present

36
Q

I50L selected by

A

Atazanavir

37
Q

I50L resistance

A

High level Atazanavir

Increase suspect. Other PIs

38
Q

Y188L selected by

A

NVP, EFV

+/- DOR

39
Q

Y188L Resistance

A

NVP, EFV

+/- DOR

40
Q

Y143 resistance

A

Raltegravir

41
Q

T66I resistance

42
Q

Q151

69SSS

A

Multi-NRTI